16 Aug 2021 07:00
Arix Bioscience PLC (ARIX) Director/PDMR Shareholding 16-Aug-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
Arix Bioscience plc Director/PDMR Shareholding Arix Bioscience plc (the "Company") today announces the annual award of nil cost options to Interim CEO Robert Lyne, which are subject to performance conditions over a three-year assessment period, in accordance with the Company's Remuneration Policy. | PDMR DEALING NOTIFICATION | | Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | | 1 | Details of the person discharging managerial responsibilities / person closely associated | | a) | Name | Robert Lyne | | 2 | Reason for the notification | | a) | Position / status | Interim Chief Executive Officer | | b) | Initial notification / Amendment | Initial Notification | | 3 | Details of issuer | | a) | Name | Arix Bioscience plc | | b) | LEI | 213800OVT3AHQCXNIX43 | | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | a) | Description of the financial instrument, type of instrument | Ordinary Shares of Arix Bioscience plc | | Identification code | GB00BD045071 | | b) | Nature of the transaction | Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") | | c) | Price(s) and volume(s) | Price(s) | Volume(s) | | Nil | 352,335 | | d) | Aggregated information | Aggregated price | Aggregated volume | | N/A (single transaction) | N/A (single transaction) | | e) | Date of the transaction | 13 August 2021 | | f) | Place of the transaction | Outside a trading venue |
For further information please contact: Optimum Strategic Communications Mary Clark, Manel Mateus +44 (0)20 8078 4357 optimum.arix@optimumcomms.com - Ends -
|
| |
| ISIN: | GB00BD045071 |
| Category Code: | DSH |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 2.3. Major shareholding notifications |
| Sequence No.: | 119950 |
| EQS News ID: | 1226354 |
| |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
